Where is US payer formulary management heading-and what can the industry do to help influence its course?
Lev Gerlovin
Advertisement
Articles by Lev Gerlovin
Advertisement
Latest Updated Articles
Restricted Access Essentials for PharmaPublished: September 14th 2015 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Organon CEO Kevin Ali to Resign Following Internal Investigation into Nexplanon Sales
2
Study Claims Ozempic Lowers Biological Age
3
Pharmaceutical Executive Daily: New Research Suggests Ozempic May Reduce Biological Age
4
GSK Agrees to $357 Million Exclusive License Agreement for Syndivia’s AntiBody-Drug Conjugate
5
